Brigette Roberts

CHIEF CORP. AFFAIRS OFFICER · QUINCE THERAPEUTICS, INC. · CIK 0001346566

FILING MIX · LIFETIME100%/0%

BUYS

SELLS

TOTAL VALUE

COMPANIES

ACTIVE SINCE

May 2026

HOLDINGS NOW

228,855

AVG SELL PX

—

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

No backtest data available for Brigette Roberts. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.

Holdings over time

QNCX · 228,855 shares · as of May 18, 2026

Trading cadence · quarterly flow

BUY ● SELL ●

2026

FLOW · 8 buys / 0 sellsCOVERAGE · 1 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
QNCX QUINCE THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	228,855	—	—	228,855	May 18, 2026	Jun 11, 2026 ↗	View →
QNCX QUINCE THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	69,350	—	—	69,350	May 18, 2026	Jun 11, 2026 ↗	View →
QNCX QUINCE THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	133,615	—	—	133,615	May 18, 2026	Jun 11, 2026 ↗	View →
QNCX QUINCE THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	34,675	—	—	34,675	May 18, 2026	Jun 11, 2026 ↗	View →
QNCX QUINCE THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	362,092	—	—	362,092	May 18, 2026	Jun 11, 2026 ↗	View →
QNCX QUINCE THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	2,070,107	—	—	2,070,107	May 18, 2026	Jun 11, 2026 ↗	View →
QNCX QUINCE THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	6,837,319	—	—	6,837,319	May 18, 2026	Jun 11, 2026 ↗	View →
QNCX QUINCE THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	124,830	—	—	124,830	May 18, 2026	Jun 11, 2026 ↗	View →

Other insiders · QNCX

Loading peer insiders…

About this filer

CIK 0001346566

ROLE

Chief Corp. Affairs Officer

PRIMARY

QNCX

COMPANIES

ACTIVE SINCE

May 2026

MARKETPEEL · /INSIDER/0001346566DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

The morning brief, before the bell.